Abstract While there has been a reduction in the number of children dying of septic shock in the richer countries of the world, septic shock remains an important cause of both mortality and morbidity for children across the world. Major reduction in the incidence of septic shock will depend on the implementation of public health measures, including immunization. Improvements in outcome of pediatric septic shock have been closely linked to early recognition (although this may be challenging in many situations); early antibiotic administration; early and appropriate fluid administration and subsequent escalation of critical care. A particular challenge has been the development and implementation of systems to ensure that these elements of management are reliably and efficiently implemented in children (even in well-resourced countries). Recent studies have highlighted the complexity of caring for patients with acute severe sepsis and septic shock in countries with fewer resources, and there is an urgent need for further studies to elucidate the implications of these studies for the management of children with septic shock, particularly in settings where additional critical care support such as inotropic or ventilator support may not be readily available.
Introduction
Immunization against organisms such as Haemophilus influenza B, Neisseria meningitidis and Streptococcus pneumonia has substantially reduced the impact of acute bacterial infections on children in richer nations of the world [1, 2] , but there are many countries where access to immunization is limited while exposure to infection is high and sepsis remains a major cause of death in children and young infants [3] across the world. Newborn infants are particularly at risk, and sepsis is the major factor in nearly 30 % of the approximately 4 million newborn deaths that occur annually across the world [4] . Even in areas where the overall bacterial sepsis rate has dropped significantly, the hospital mortality related to bacterial sepsis had not improved [5 • ].
Improved recognition and early, goal-directed, timesensitive management of septic shock has resulted in a dramatic reduction in the mortality of children who present in septic shock. In the 1960s mortality from septic shock in children was close to 100 % [6] , and in many countries today mortality from pediatric septic shock is 10 % or less [7, 8] (better in previously well children than in those with chronic illness) although there may still be significant associated morbidity [9] [10] [11] .
An underlying theme is that significant improvements in the outcomes of patients with septic shock have been achieved by the use of structured approaches to management [12] [13] [14] , and many of the interventions that have made the most impact have been relatively simple [15, 16] .
This review will consider factors that should be weighed in the recognition of septic shock in the clinical context, and then consider advances and controversies in the management of children with septic shock. It will not focus on the challenges of treating neonates and particularly preterm infants with septic shock.
Recognition
Recognition of the possibility of septic shock as a cause of symptoms in a particular child is fundamental to the management of septic shock as the earlier therapy is initiated, the better the outcome is likely to be [12, 17, 18] . Different age groups are characterized by different organisms and pathophysiological mechanisms. There are different responses to sepsis in adults and children (as recently reviewed by Aneja and Carcillo [19] ), in children of different ages [20] , and in neonates (in whom responses even vary between term and preterm infants) [20] . Adults typically present with ''warm shock'' (high cardiac output and low systemic vascular resistance manifesting with tachycardia, flash capillary refill, wide pulse pressures) while children more frequently present with ''cold shock'' (low cardiac output and high systemic vascular resistance manifesting with tachycardia, mottled pale skin, prolonged capillary refill and decreased peripheral pulses). Not only are there age-related differences in hemodynamic presentations, but the particular organisms (or source of the organisms) may affect the nature of the hemodynamic presentation in severe sepsis. Furthermore the presentations of septic shock are dynamic and may change over time, even in the same patient.
While recognition of septic shock may be relatively straightforward in the context of an intensive care unit that deals with many such patients, it is much more challenging to ensure that early signs of septic shock are recognized in children initially presenting to healthcare services where such problems are much less frequent [21, 22] . Studies of meningococcal disease suggest that while the ''full-blown'' picture may be easy to recognize, the clinical features in the early phase of the disease may be very non-specific and subtle [23] . Early diagnosis is also difficult in settings where clinicians are not dealing with many children as the clinical features of septic shock differ between adults and children [19] .
Clinical signs of sepsis are the result of an interaction between the particular pathogen(s) and the responses of the particular patient to that pathogen [24] . Given the wide range of potential pathogens and the range of host responses, it is inevitable that there will be a range of clinical features related to septic shock. This is further complicated by the range of hemodynamics [25, 26] encountered in children with septic shock. In a recent study of patients with fluid resistant (who required 40 mL/kg or more of resuscitation) septic shock [27] , patients with central-line-associated infection (predominantly Staphylococcus epidermidis and Klebsiella pneumoniae) presented with high cardiac output and low systemic vascular resistance while patients with community acquired sepsis presented with low or normal cardiac output and high systemic vascular resistance. Furthermore, the clinical picture of ''septic shock'' can occur in response to a wide range of pathogens including viruses [28] [29] [30] , malaria [31] , rickettsiae and a range of bacterial pathogens.
Recognition of septic shock requires first the recognition of shock, and then the attribution of that shock to infection. Data from primary care settings suggest that clinical and laboratory signs may be useful in the diagnosis of severe sepsis in developed countries [22, 23, 32 • , 33] . Clinicians' ''gut feelings'' (including a sense from the parents that this illness was ''different'') are also significant [34] .
Clinical definitions for septic shock as laid out in the ACCM/PALS [Pediatric Advanced life support] guidelines [35] focus on the clinical features of shock which include: ''sustained tachycardia'' (the definitions of which depend on age, and which may be absent in hypothermic patients), diminished peripheral pulses compared with central pulses, delayed capillary refill (defined as [2 s) or flash capillary refill, altered mental status, mottled cool extremities, or decreased urine output (\1 mL/kg/h)-all signs of inadequate end-organ perfusion. Hypotension (\5th percentile for age) is considered confirmatory but not necessary [35] . It is important to note that this clinical definition is different from that laid out in consensus statements on definitions of severe sepsis in children [36] which were focused on providing definitions for clinical research, and not on ensuring that sepsis was diagnosed early and effectively. In particular previous administration of fluid boluses or need for vasoactive drugs are not required in the ACCCM/PALS guidelines (see Table 1 ). Use of different guidelines or definitions for septic shock is related to significant differences in diagnosis [37] .
Although Carcillo et al. [9] have shown that early treatment of septic shock based on clinical signs such as capillary refill has improved outcomes, other studies [38, 39] have shown poor reproducibility between observers in the assessment of capillary refill and in the prognostic significance of the sign. Tachycardia (particularly persistent tachycardia), together with delayed capillary refill were features of shock in a large group of children [9] , and in that study persistence of tachycardia, delayed capillary refill and systolic hypotension were strongly associated with mortality. The shock index (ratio of heart rate to systolic arterial pressure) [9, 40] may be a useful clinical parameter to highlight the presence of shock (and to monitor response to therapy).
In neonates it may be impossible to differentiate septic shock from duct-dependent cardiac lesions and prostaglandin infusions should be initiated together with antibiotic therapy and appropriate cardiovascular support until such time as cardiac lesions have been excluded.
Diagnostic Tests
Once septic shock has been considered as a diagnosis, diagnostic tests should be collected as soon as possible (but without delaying the initiation of therapy). The tests required for the diagnosis of the etiology of ''septic shock'' differ across the world depending on the prevalent pathogens. In much of Europe and the United States of America bacterial and some viral pathogens are the most likely causes of septic shock. However in other parts of the world conditions such as malaria and dengue need to be considered and may be impossible to differentiate from bacterial sepsis clinically. One of the underlying problems with the management of severe sepsis throughout the developing world is the lack of adequate diagnostics for infectious agents. Recently, the bacterial culture rate in a large cohort of children with severe sepsis in East Africa [41] was only 12 % (while 57 % were positive for malaria parasites).
Culture is the usual standard for the diagnosis of severe bacterial infections. Culture unfortunately may take many hours (or days) to provide a result, and the sensitivity of blood cultures in children is limited by the small size of the blood sample that is collected [42] . However, recently multiplex PCR [43] (the LightCycler SeptiFast test) has been used for diagnosis of bloodstream infections in neonates and children. The time to result was only 6 h, and the test may still be positive following the administration of antibiotics. This holds potential for future widespread clinical implementation, but cost is likely to be a limiting factor in many parts of the world.
The use of a wide range of markers of sepsis has been reported in the literature. It would seem that raised white cell counts are not helpful in diagnosing sepsis, while procalcitonin and C-reactive protein may be more useful [33] . A study in 90 children with severe sepsis or septic shock [44] showed that procalcitonin levels at both admission and 6 h post admission were significantly higher in septic shock patients. Similar results were shown in another study of 94 children in PICU [45] . Serum ferritin levels were associated with outcome in patients with severe sepsis or septic shock, and a ferritin level of [500 ng/mL was associated with a 3.2 (1.3-7.9) relative risk of death (p = 0.01) [46] . In many areas of the world there is limited laboratory support, and clinicians have little choice but to focus on known epidemiology and treat empirically based on most likely pathogens [47] .
The presence of a raised DIC score (an 8-point score calculated from the sum of points allocated the parameters of platelet numbers, fibrinogen levels, fibrin degradation product levels and prothrombin time) was associated with increased mortality in children with sepsis and shock in a study in India [48] .
Management
The themes of the currently accepted guidelines for management of pediatric septic shock are: Goal-directed, early administration of effective antibiotics; early and aggressive fluid resuscitation; rapid escalation of cardiovascular support if fluid resuscitation does not have the desired effect.
Antibiotics
Given that the negative consequences of early initiation of antibiotics are low, particularly if the antibiotics are subsequently stopped in a timely fashion (if results show that bacterial sepsis can be excluded) and given that delays in appropriate antibiotic administration are associated with adverse outcomes [49] [50] [51] [52] 53 •• ], there should be a low threshold for early administration of antibiotics. In particular the threshold for initiation of treatment for sepsis should be extremely low in children at increased risk of severe sepsis (including neonates and young infants; children with immunosuppression or malignancy or abnormalities of protective skin layers; children with traumatic injuries and burn injuries [54] ; and children who have recently undergone major surgery) [49, 50] . If infection is subsequently ruled out, then antibiotic therapy should be stopped. If a particular pathogen is identified, then antibiotic coverage can be narrowed. There is evidence from the adult literature that delayed administration of antibiotics to patients with septic shock is associated with significant increases in mortality [52] . Likewise administration of the inappropriate antibiotic is associated with an increase in mortality [53 • • ] while use of appropriate combination antibiotic therapy is associated with improved outcomes [51] .
Centers across the world have reported that achieving early administration of antibiotics to patients with septic shock may be surprisingly difficult [17, 55 • , 56, 57] and institutions that may need to treat children with septic shock have to develop systems to ensure that broad spectrum (appropriate to the local microbiology profile) antibiotics are readily available and can be administered in appropriate pediatric dosage within a short space of time. Intravenous administration of antibiotics is the most effective way of ensuring adequate therapeutic levels.
Although there is a paucity of pediatric literature related to the pharmacodynamics and kinetics of antibiotics in severe sepsis, there is a body of evidence in the adult literature showing that antibiotic levels of drugs such as ertapenem [58, 59] , beta-lactams and vancomycin may vary considerably in severe sepsis depending on the specific context [59] [60] [61] [62] [63] , including albumin and creatinine levels. Drugs such as aminoglycosides may accumulate in patients with severe sepsis, but there may also be augmented excretion of antibiotics such as beta-lactams with resultant poor therapeutic levels [64] . In patients on continuous renal replacement therapy there also may be very significant differences in antibiotic levels achieved [65] . Although there is no definitive evidence that monitoring of antibiotic drug levels will improve outcomes, there is an urgent need for investigation of this particular question [66] .
Fluid Resuscitation
There is strong consensus in the guidelines for the management of septic shock in children that early and aggressive fluid resuscitation is appropriate [12, 67, 68] . In addition, a number of studies have shown that where adherence with these guidelines has been achieved, there was a substantial reduction in mortality or hospital stay related to septic shock [8, 55 • , 69] .
While there is considerable debate about which fluids should be used for volume resuscitation in septic shock, there is no definitive evidence robust enough to make firm recommendations [70] . Currently fluids such as 0.9 % saline and Ringer's lactate are relatively inexpensive and have not been shown to be inferior to colloids. Adult studies suggest that colloids (both albumen and starches) hold little benefit in shock [71, 72] relative to crystalloids.
Vascular access in small children, particularly those in septic shock, may be difficult, and early resort to intraosseous access may enable fluid resuscitation [73] . Once intra-osseous vascular access has been established, it is easier to provide support and appropriate analgesia to establish more secure vascular access.
Recently the FEAST study [41] provided a surprising result in demonstrating that administration of a fluid bolus (either saline or albumen) was associated with increased mortality in a group of children with a severe febrile illness in East Africa. That study was well-designed and robust, with over 3,000 patients enrolled, and intriguingly the outcome was contrary to the expectations of clinical staff involved in the study. The implications of that study remain to be elucidated. Some of the factors that may be related to the outcome in that particular group of patients include: high rates of malaria; significant anemia; lack of identification of pathogens in the majority of the patients (only 12 % had positive blood cultures and there were no other tests for bacterial or viral pathogens); lack of availability of respiratory support (ventilation was not available, and in some cases access to oxygen was extremely limited). The result was particularly surprising in light of previous studies from that region demonstrating improvements in patients with severe malaria treated with fluid boluses [74, 75] . It is relevant that although early antibiotic administration, vigorous volume resuscitation, and early use of inotropic support was associated with a dramatic improvement in outcomes from severe meningococcal disease in the UK [76] , early endotracheal intubation and ventilation was provided for these patients.
In the context of dengue, it has been clearly demonstrated that therapy with a limited fluid bolus (15 mL/kg over a 1-h period, followed by 10 mL/kg over the second hour) is life-saving in children with moderately severe dengue shock [77, 78] . In terms of clinical features septic shock and dengue shock clearly have some overlap although there may be some distinguishing features [79] .
In countries where respiratory support is not always available, a more conservative approach to fluid administration may well be justified in septic shock [80] . This may be even more relevant in children with significant malnutrition, although the evidence base for this is extremely limited [81, 82] .
Once patients have been resuscitated, a conservative approach to fluid therapy should be employed (particularly in patients with renal dysfunction) as fluid overload has been clearly associated with increased mortality (see below).
Cardiovascular Support
Guidelines [12, 83] recommend the use of dopamine in patients with septic shock who have failed to respond adequately to 60 mL/kg or more of fluid resuscitation. Importantly, initiation of this support should not wait until central venous access has been established (although it is safer to administer vasoactive drugs through central venous access together with very close hemodynamic monitoring). At a later stage in the resuscitation process, there are recommendations for different combinations of cardiovascular drugs, depending on the particular hemodynamic profile of the patient. It is important to note that clinical profiles may change over time in individual patients, and therapy must be monitored (this may include invasive measurements ranging from arterial and central lines to pulmonary artery catheters; mixed or superior vena cava venous saturation; or noninvasive Doppler studies) if not continuously, at least very frequently. In the setting of fluid and inotropic refractory shock it is suggested that epinephrine could be used instead of dopamine for the patient with ''cold shock'', while norepinephrine could be added for the patients with ''warm shock''. Arginine vasopressin or analogues such as terlipressin have also been used in small numbers of patients with catecholamine-refractory vasodilatory shock [84] [85] [86] .
Respiratory Support
Early initiation of respiratory support is highlighted in all the guidelines. Certainly, oxygen therapy should be initiated early in shocked children, although there are concerns about the impact of hyperoxia on tissue damage, particularly in patients with limited anti-oxidant capacity [87] . Once initial resuscitation has been achieved, oxygen therapy should be titrated to avoid hyperoxia. There is no evidence that hypocarbia during ventilation for sepsis is beneficial (and real evidence that over-ventilation may reduce preload to the right heart with subsequent decrease in cardiac output and can also lead to cerebral vasoconstriction and secondary ischemic brain injury), and some evidence that hypercarbia is not harmful and may well be beneficial [88] . In all cases ventilation should be provided using lung-protective strategies incorporating a tidal volume of approximately 6 mL/kg and a peak pressure of \30 cm H 2 O [89] . Strategies such as high-frequency oscillatory ventilation and prone ventilation may be useful adjuncts in patients with acute respiratory distress syndrome.
While early initiation of ventilator support has been recommended, the endotracheal intubation of patients in septic shock may be a high-risk procedure with morbidity related to the agents used for anesthesia [90] . Etomidate is not recommended because of its effects on the adrenocorticoid axis [91, 92] ; ketamine has been recommended as a useful agent as it tends to cause less hypotension (although patients with depleted catecholamine stores may be at risk for hypotension), while propofol is not recommended because of the potentiation of its effects encountered during shock [93] . Initiation of positive-pressure ventilation may cause a drop in cardiac output in patients who are relatively hypovolemic (although positive-pressure ventilation may also improve cardiac output in the setting of left ventricular dysfunction). Thus, ideally, patients should be adequately volume resuscitated and started on inotropic infusions (by peripheral vein if necessary) prior to intubation.
The use of high-flow humidified nasal oxygen therapy may be a useful adjunct to respiratory support in pediatric septic shock over a range of age-groups, as it has shown benefits in respiratory support in a variety of contexts [94] [95] [96] .
In general, the guidelines have focused on clinically apparent hemodynamic goals of treatment, such as return of normal blood pressure, heart rate and capillary refill. Some studies have added other goals, such as superior vena cava saturations [8] . In that study there was a substantial improvement in mortality in the group where superior vena caval saturations were targeted, but the actual difference in therapy was that these patients received more fluid in the first hour of resuscitation. The microcirculation in pediatric shock has recently been reviewed by Top et al. [97] , showing that failure of return to normal of the micro-circulation is related to poor outcomes from septic shock, and suggesting that there may be a clinical role in the future for techniques that assess the micro-circulation in children with septic shock. Currently assessment of the micro-circulation is difficult in the clinical context.
Renal Support Therapy
Mortality in children with septic shock who require renal replacement therapy may be very high [98] , particularly in younger children who require significant inotropic support. Several studies of the need for renal support therapy in septic shock have highlighted the fact that significant fluid overload in patients prior to the onset of dialysis is associated with higher mortality [99, 100] . There is no evidence suggesting that particular forms of renal support therapy (e.g., peritoneal dialysis, hemodialysis or continuous hemofiltration) are of particular benefit in septic shock, although technical considerations may give rise to preferences for the mode of support used. There is some limited evidence that plasmapheresis may improve outcomes from severe sepsis [101] , while a recent study reported that in a group of 12 previously well patients with multi-system organ failure related to septic shock (8 with meningococcemia), early initiation of therapeutic plasma exchange was associated with good quality survival in 11 [101] .
Pyrexia and Management
Treatment of pyrexia has recently been reviewed by Launey et al. [102] . Pyrexia is closely associated with infection, and studies on the adverse effects of hyperpyrexia on neurological injury have driven intensivists towards an aggressive approach to reduce fever in ICU patients. There is considerable experimental evidence that pyrexia may be beneficial in terms of clearing infection and surviving sepsis. Thus there is little indication for aggressive attempts to reduce pyrexia in patients with severe sepsis, unless complications of hyperpyrexia are possible.
Tight Glucose Control
Hyperglycemia has been related to adverse outcomes in critically ill children in a variety of situations for some years [103] . Recently, the literature on adults has focused on ''tight glucose control'' as an essential component of therapy for severe sepsis, although this has been controversial. Despite earlier positive studies, there are some recent studies that suggest that the adverse consequences of tight glucose control may outweigh the benefits [104] . Children may have a different physiological basis for hyperglycemia in severe illness relative to adults, and there is very limited data to support this approach in children with septic shock. However, persistent hyperglycemia may be a marker of inadequate resuscitation (or ongoing stress). Severe hyperglycemia should probably be treated with insulin infusions (cautiously).
Steroids
The guidelines for management of septic shock recommend the administration of hydrocortisone to children with catecholamine-resistant septic shock when they are at risk of adrenal insufficiency. In the largest study of children with severe sepsis to date, the use of steroids was not associated with any significant improvement in outcome [105] .
A retrospective study of children with systemic inflammatory response syndrome and fluid refractory shock who had received low-dose hydrocortisone and fludrocortisone supplementation showed no difference in duration of vasopressor support, but the septic shock group who had received fludrocortisone and hydrocortisone received a shorter duration of support with norepinephrine [106] .
Adherence to Bundles
Since the publication of the Surviving Sepsis Guidelines and the updated guidelines [12, 13] , a number of studies have shown that adherence to guidelines has been associated with improved patient outcomes [55 • , 69] . However, several studies have shown that implementation of guidelines may not be straightforward, even in settings which are relatively well resourced [55 • , 107] .
Paul et al. [55 • ] demonstrated that although they had poor adherence to guidelines, adherence was associated with significantly shorter hospital stay. Recently Larsen et al. [17] implemented a protocol for the recognition and management of septic shock in their emergency department. Over a 5-year period, they identified 297 children who met septic shock criteria. Implementation of the guideline was associated with a decrease in duration of hospital stay, but no change in mortality. However, this was in the context of a mortality of 6.3 %. Han et al. [69] showed a substantially lower mortality in children presenting to a community hospital with septic shock where providers followed guidelines for early reversal of shock.
The development of a particular septic shock team has been shown to significantly improve the outcomes in adults with septic shock [108] .
As part of developing systems and structures for management of children in septic shock, it is important to review and consider the need for stabilization and transport of children with septic shock [109] . It is also important to focus on meeting the particular needs of children who are poor; at particular risk for septic shock; or both [110] .
Nosocomial Infection
Children with septic shock may have immunoparalysis [111] , and particular attention must be paid to ensuring that risks of nosocomial infection are decreased as far as possible [111] . It is particularly important in environments where many children have infections, and the number of available staff is limited to focus on the needs for reduction of patient-to-patient transmission of infection.
Conclusions
Septic shock remains a significant cause of pediatric mortality and morbidity across the world, despite advances in both public health and critical care. Implementation of guidelines has been associated with improvements in outcomes, although compliance rates remain surprisingly low. Importantly, the major components of the therapy-such as early antibiotic administration, fluid resuscitation and ongoing interventions such as inotropic support-are not particularly expensive and can be provided to many children (even in resource-limited settings). Unfortunately, management of septic shock may be more complex in resource-limited settings for a variety of reasons, including the range of pathogens, underlying factors such as chronic disease and malnutrition, and limited access to respiratory support. Particular do's and don'ts in the recognition and management of septic shock have been summarized in Table 2 .
While optimization of therapy for severe sepsis in resource-limited environments must become a central focus for future research, there is a need for greater understanding of how effective and timely therapy can be made available to children in all settings. There is a hope that with early and effective systems to prevent severe sepsis where possible but also to treat severe sepsis appropriately substantial reductions in pediatric mortality and morbidity across the world can be achieved. 
